Cargando…
Cisplatin in Ovarian Cancer Treatment—Known Limitations in Therapy Force New Solutions
Cisplatin is one of the most commonly used anticancer drugs worldwide. It is mainly used in the treatment of ovarian cancer, but also used in testicular, bladder and lung cancers. The significant advantage of this drug is the multidirectional mechanism of its anticancer action, with the most importa...
Autores principales: | Zoń, Aleksandra, Bednarek, Ilona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146189/ https://www.ncbi.nlm.nih.gov/pubmed/37108749 http://dx.doi.org/10.3390/ijms24087585 |
Ejemplares similares
-
The Effect of α-Mangostin and Cisplatin on Ovarian Cancer Cells and the Microenvironment
por: Borzdziłowska, Paulina, et al.
Publicado: (2022) -
Alpha Mangostin and Cisplatin as Modulators of Exosomal Interaction of Ovarian Cancer Cell with Fibroblasts
por: Borzdziłowska, Paulina, et al.
Publicado: (2022) -
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
por: Bieg, Dominik, et al.
Publicado: (2018) -
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
por: Bieg, Dominik, et al.
Publicado: (2018) -
Lesser-Known Molecules in Ovarian Carcinogenesis
por: Lozneanu, Ludmila, et al.
Publicado: (2015)